Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
JAMA Network Open|November 6, 2024
Safety of Simultaneous vs Sequential mRNA COVID-19 and Inactivated Influenza Vaccines: A Randomized Clinical TrialEmmanuel B Walter, Elizabeth P Schlaudecker, Kawsar R Talaat, et al.
Lancet Regional Health. Americas|April 28, 2025
Immunologic changes in the peripheral blood transcriptome of individuals with early-stage chronic Chagas cardiomyopathy: a cross-sectional studyCarolina Duque, Jaime So, Yagahira E Castro-Sesquen, et al.
Biorxiv : the Preprint Server for Biology|October 24, 2023
Immunologic changes are detectable in the peripheral blood transcriptome of clinically asymptomatic Chagas cardiomyopathy patientsCarolina Duque, Jaime So, Yagahira E Castro-Sesquen, et al.
Clinical Trials (London, England)|October 28, 2021
A site assessment tool for inpatient controlled human infection models for enteric disease pathogensChad K Porter, Katherine J Detizio, Nicole Maier, et al.
Ebiomedicine|April 16, 2021
Human challenge study with a Shigella bioconjugate vaccine: Analyses of clinical efficacy and correlate of protectionKawsar R Talaat, Cristina Alaimo, Patricia Martin, et al.
The Journal of Infectious Diseases|January 19, 2013
A single dose of any of four different live attenuated tetravalent dengue vaccines is safe and immunogenic in flavivirus-naive adults: a randomized, double-blind clinical trialAnna P Durbin, Beth D Kirkpatrick, Kristen K Pierce, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 22, 2018
Enterotoxigenic <i>E. coli</i> virulence gene regulation in human infectionsAlexander A Crofts, Simone M Giovanetti, Erica J Rubin, et al.
Ebiomedicine|April 4, 2021
Immune response characterization in a human challenge study with a Shigella flexneri 2a bioconjugate vaccineKristen A Clarkson, Kawsar R Talaat, Cristina Alaimo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 18, 2017
Rifaximin Fails to Prevent Campylobacteriosis in the Human Challenge Model: A Randomized, Double-Blind, Placebo-Controlled TrialJoanna E Rimmer, Clayton Harro, David A Sack, et al.
The New England Journal of Medicine|April 8, 2026
Immunogenicity and Safety of vYF, a Yellow Fever Vaccine - A Phase 2 TrialEmmanuel Feroldi, Mark J Mulligan, Kawsar R Talaat, et al.
Pageof 6